Sponsor study identifier
interventional
140
1 country
1
Study Start
November 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
October 2010
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
October 2010
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Recent work at St. Thomas' has validated an innovative new design of a multichannel intraluminal impedance (MII) catheter that is sensitive to variation in oesophageal volume in healthy volunteers and patients. This project will establish the clinical value of volume sensitive MII (vMII) compared to conventional MII acquired simultaneously by the same catheter (ROC analysis). Studies will assess:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 2010
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 2007
Date type not reportedThis date has not been verified as actual or estimated.
January 15, 2008
Actual (reported)January 30, 2008
Actual (reported)October 2010
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
October 2010
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Does vMII provide an accurate assessment of volume in disease?
3 years
Does vMII assessment of volume improve the accuracy with which 'events' are associated with symp?
3 years
Does symp improvement post treatment correlate with reduced 'volume events'?.
3 years
Long vs Short Myotomy repair of Achalasia
Conservative Management
Partial vs Full Fundoplication repair
These entries preserve how the registry describes the intervention. Their treatment roles are shown separately from molecular identities.
Grouped treatment entry
domperidone or esomeprazole (Conservative management)
The registry names several treatments. This does not confirm that participants received them together or that they form a single product.
View registry recordOesophageal Laboratory, GSTT
London, London, SE1 7EH, United Kingdom
Mark Fox, MD
Honorary Consultant and Senior Lecturer
First Submitted
January 15, 2008
First Posted
January 30, 2008
Study Start
November 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
October 2010
Estimated (date passed)Clinical Impact of Peroral Endoscopic Myotomy for Esophageal Achalasia
Endoscopic Myotomy of the Lower Esophageal Sphincter for Achalasia
esomeprazole 40 mg vs no esomeprazole
Conservative management for dysphagia not referred for surgery. Conservative management: balloon dilatation or drugs such as domperidone 10 mg or esomeprazole 40 mg
Esomeprazole vs no esomeprazole for GORD not referred for surgery
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
October 2010
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
August 3, 2009
Record last verified: 2009-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: